BLAINJECTIONINJECTABLE
Approved
Nov 1976
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PULMOLITE is a Technetium Tc-99m albumin aggregated injection kit, a radiopharmaceutical diagnostic agent used for pulmonary imaging. It contains human serum albumin aggregated particles labeled with radioactive Tc-99m for intravenous injection. The product is used to visualize lung perfusion and detect abnormalities in pulmonary blood flow.
LOE Approaching
Product is in late-lifecycle phase with minimal linked job opportunities; team is likely operating in maintenance and transition mode rather than growth expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PULMOLITE offers limited career advancement opportunities given its LOE status and zero linked job openings. The role would focus on defending market position and managing existing customer relationships rather than driving growth or innovation.
Product SpecialistHospital Account Manager
Worked on PULMOLITE at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.